Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
about
Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseThe Role of Autophagy in Hepatocellular CarcinomaRaf-interactome in tuning the complexity and diversity of Raf function.Calorie restriction combined with resveratrol induces autophagy and protects 26-month-old rat hearts from doxorubicin-induced toxicity20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicinWithaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancerSchedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinomaA novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission.Autophagy: A novel therapeutic target for hepatocarcinoma (Review).Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy.Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.The Complex Link between Apoptosis and Autophagy: a Promising New Role for RB.Quercetin-mediated synthesis of graphene oxide-silver nanoparticle nanocomposites: a suitable alternative nanotherapy for neuroblastoma.OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.Ursolic acid promotes cancer cell death by inducing Atg5-dependent autophagy.Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines.
P2860
Q26745320-801FAA84-4AD0-42DF-AFCD-84CF44895869Q26777419-5117DF58-6D41-4299-8DD9-9868A6D7865CQ27692653-55FE6513-A57F-442B-94FC-0C03AA83B7EDQ34098331-0D7C8C8E-0D08-409F-926F-CE028E4561DFQ34101000-4A8F9CB0-BF47-4D35-8D7F-FF24A3AF9570Q34292101-E5D6ABF0-0DD2-4C68-8DC4-722C47F22E4AQ34877852-0F9010D5-562F-48E5-9180-B1520DD92ABFQ36111625-469A7381-C279-4B42-B818-A599BC17967AQ37720015-D17DDF4F-4F69-408A-A2ED-226DF442F024Q38916622-5584DE37-1CAC-47A4-B716-A9431B340AE1Q39030337-F8378451-E384-4CB6-A6F2-FCF51383E417Q39043141-FA2E3B6D-531B-43B5-ACFE-24134F848D93Q40071681-2139507B-9020-4E27-8EB6-ADC87FAF9E11Q42362014-0804D23A-A2D6-48C3-831B-9C62BE93B6F5Q44811933-F3D088B3-EB18-40D1-A5C7-0018A89A77DEQ47405898-23C58B6B-AD3D-4B33-98DF-4F9C9BF66BCEQ51284365-7457F0E3-FE93-4188-AF1C-6197C297DDC5
P2860
Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@en
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@nl
type
label
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@en
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@nl
prefLabel
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@en
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@nl
P2093
P2860
P1433
P1476
Inhibition of doxorubicin-indu ...... egulated kinase counteraction.
@en
P2093
Irena Manov
Rinata Broneshter
Theodore C Iancu
Yulia Pollak
P2860
P304
P356
10.1111/J.1742-4658.2011.08271.X
P407
P577
2011-09-01T00:00:00Z